Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
PepsiCo
PEP
|
+$199M |
| 2 |
Johnson & Johnson
JNJ
|
+$187M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$187M |
| 4 |
Chubb
CB
|
+$158M |
| 5 |
Eli Lilly
LLY
|
+$135M |
Top Sells
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$165M |
| 5 |
Gilead Sciences
GILD
|
+$147M |
Sector Composition
| 1 | Financials | 11.91% |
| 2 | Healthcare | 11.63% |
| 3 | Technology | 11.32% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Staples | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
DMC Global
BOOM
$144M
| $761K | ﹤0.01% |
117,500
-9,900
| -8% | -$64.1K |
|
2702
Forward Industries
FORD
$59.2M
| $759K | ﹤0.01% |
58,870
+830
| +1% | +$10.7K |
|
2703
Health Care Select Sector SPDR Fund
XLV
$34.7B
| $759K | ﹤0.01% |
11,200
-42,300
| -79% | -$2.87M |
|
2704
First Horizon
FHN
$11.6B
| $758K | ﹤0.01% |
+57,900
| New | +$758K |
|
2705
Lear
LEA
$5.78B
| $756K | ﹤0.01% |
+6,800
| New | +$756K |
|
|
CPE
2706
DELISTED
Callon Petroleum Company
CPE
| $756K | ﹤0.01% |
+8,539
| New | +$756K |
|
|
CBR
2707
DELISTED
CIBER Inc.
CBR
| $756K | ﹤0.01% |
358,100
+87,500
| +32% | +$185K |
|
|
DRYS
2708
DELISTED
DryShips Inc. Common Stock
DRYS
| $753K | ﹤0.01% |
1
| – | – |
|
|
KIN
2709
DELISTED
Kindred Biosciences, Inc.
KIN
| $752K | ﹤0.01% |
217,900
-48,002
| -18% | -$166K |
|
2710
AMCON Distributing
DIT
$78.1M
| $751K | ﹤0.01% |
9,200
+100
| +1% | +$8.16K |
|
2711
Greif Class B
GEF.B
$2.48B
| $749K | ﹤0.01% |
16,000
+500
| +3% | +$23.4K |
|
2712
MiMedx Group
MDXG
$1.05B
| $747K | ﹤0.01% |
85,500
+65,900
| +336% | +$576K |
|
2713
Cantaloupe
CTLP
$793M
| $743K | ﹤0.01% |
+170,300
| New | +$743K |
|
|
UBP
2714
DELISTED
Urstadt Biddle Properties Inc.
UBP
| $743K | ﹤0.01% |
41,100
+600
| +1% | +$10.8K |
|
|
BLT
2715
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $743K | ﹤0.01% |
74,400
-267,300
| -78% | -$2.67M |
|
|
SALM
2716
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $741K | ﹤0.01% |
128,600
+300
| +0.2% | +$1.73K |
|
|
COB
2717
DELISTED
CommunityOne Bancorp
COB
| $740K | ﹤0.01% |
55,700
+15,100
| +37% | +$201K |
|
|
NW.PRC.CL
2718
DELISTED
Natwest Bank Ads Series C
NW.PRC.CL
| $736K | ﹤0.01% |
28,500
+6,178
| +28% | +$160K |
|
2719
MediciNova
MNOV
$61.8M
| $735K | ﹤0.01% |
100,100
+1,900
| +2% | +$14K |
|
2720
Scully Royalty
SRL
$81.5M
| $733K | ﹤0.01% |
74,080
+11,020
| +17% | +$109K |
|
2721
LiveRamp
RAMP
$1.77B
| $730K | ﹤0.01% |
34,045
-19,500
| -36% | -$418K |
|
|
OXGN
2722
DELISTED
OXIGENE INC COM
OXGN
| $730K | ﹤0.01% |
919,100
+99,300
| +12% | +$78.9K |
|
|
SHYF
2723
DELISTED
The Shyft Group
SHYF
| $728K | ﹤0.01% |
184,200
+82,000
| +80% | +$324K |
|
|
GENE
2724
DELISTED
Genetic Technologies Ltd.
GENE
| $726K | ﹤0.01% |
15,719
-155
| -1% | -$7.16K |
|
2725
Verastem
VSTM
$580M
| $723K | ﹤0.01% |
38,120
+31,041
| +438% | +$589K |
|